ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.12% | 7.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.12% | 7.61% | |||
| Cost of Revenue | 2.10% | 38.57% | |||
| Gross Profit | 2.12% | 3.42% | |||
| SG&A Expenses | 2.12% | -14.59% | |||
| Depreciation & Amortization | 2.11% | 2.81% | |||
| Other Operating Expenses | 2.12% | 228.12% | |||
| Total Operating Expenses | 2.12% | -0.70% | |||
| Operating Income | -2.12% | 5.01% | |||
| Income Before Tax | -2.12% | -4.40% | |||
| Income Tax Expenses | 2.13% | 30.56% | |||
| Earnings from Continuing Operations | -2.12% | -4.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | -4.43% | |||
| EBIT | -2.12% | 5.01% | |||
| EBITDA | -8.83% | -9.01% | |||
| EPS Basic | 0.00% | -- | |||
| Normalized Basic EPS | 0.00% | -- | |||
| EPS Diluted | 0.00% | -- | |||
| Normalized Diluted EPS | 0.00% | -- | |||
| Average Basic Shares Outstanding | 0.00% | -99.90% | |||
| Average Diluted Shares Outstanding | 0.00% | -99.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||